The Impact Of Medicare Part D On Prescription Drug Use By The Elderly-Reference-Cited by-同舟云学术

The Impact Of Medicare Part D On Prescription Drug Use By The Elderly

Published:2007-11 Issue:6 Volume:26 Page:1735-1744
ISSN:0278-2715
Container-title:Health Affairs
language:en
Short-container-title:Health Affairs

Author:

Lichtenberg Frank R.,Sun Shawn X.¹

Affiliation:

1. Columbia University in New York City

Publisher

Health Affairs (Project Hope)

Subject

Health Policy

Reference5 articles.

1. Riding The Rollercoaster: The Ups And Downs In Out-Of-Pocket Spending Under The Standard Medicare Drug Benefit

2. Riding The Rollercoaster: The Ups And Downs In Out-Of-Pocket Spending Under The Standard Medicare Drug Benefit

3. Does Public Insurance Crowd out Private Insurance?

4. Using Discontinuous Eligibility Rules to Identify the Effects of the Federal Medicaid Expansions on Low-Income Children

5. D.P. Goldman , G.F. Joyce, and P. Karaca-Mandic, “Varying Pharmacy Benefits with Clinical Status: The Case of Cholesterol-Lowering Therapy,” American Journal of Managed Care 12 , no. 1 ( 2006 ): 21 –28.

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimating price elasticities of demand for pain relief drugs: evidence from Medicare Part D;International Journal of Health Economics and Management;2024-08-02

2. Implications of the Inflation Reduction Act for the biotechnology industry; sensitivity of investment and valuation to drug price indices and market conditions;2024-06-28

3. Patient-Centered Practice Guidelines: GRADEing Evidence to Incorporate Certainty, Balance Between Benefits and Harms, Equity, Feasibility, and Cost-Effectiveness;The Journal of Allergy and Clinical Immunology: In Practice;2024-03

4. Considering Returns on Federal Investment in the Negotiated “Maximum Fair Price” of Drugs Under the Inflation Reduction Act: an Analysis;2024-02-28

5. The effect of prescription drug insurance on the incidence of potentially inappropriate prescribing: Evidence from Medicare Part D;Health Economics;2023-10-21